Company Overview

Development Stage

About the Company

[Summary] 研发原创性的天然全人源抗体类新药

关于泰诺麦博
珠海泰诺麦博制药股份有限公司(简称“泰诺麦博”及“Trinomab”)成立于2015年,是一家面向全球市场、致力于血液制品替代疗法的创新生物制药企业。2026年7月,泰诺麦博(股票代码:688806)正式在上海证券交易所科创板挂牌上市。
公司凭借自主开发的“高通量全人源单克隆抗体研发综合技术平台HitmAb®”等技术平台不断在全人源单抗领域探索抗体药物更高安全性与有效性的可能性,并已成功开发出多个抗体分子作为候选药物,已覆盖感染性疾病以及疼痛类疾病等疾病领域。其中,全球同类首创(First-in-Class)的斯泰度塔单抗注射液已获批准上市。斯泰度塔单抗注射液是抗感染领域*被CDE认定为突破性治疗药物的国产创新生物药,III期临床研究成果已先后受邀在2024年美国急诊医师学会年会(American College of Emergency Physicians, ACEP)及2024年第18届欧洲急诊医学大会(European Emergency Medicine Congress, EUSEM)中现场报告,革新了全球破伤风预防领域的临床用药方案。公司的另一款核心产品全球首款一针具备9个月保护数据的抗RSV单抗--新多妥(通用名:芮特韦拜单抗注射液,曾用名:TNM001 注射液)于2026年9月3日获批上市。该产品新药上市申请(NDA)于2026年2月正式获得国家药品监督管理局(CDE)受理,3月被纳入优先审评审批程序,同年获国家科技重大专项立项。
公司以“创造临床价值”为导向,秉持差异化创新和竞争战略,致力于全人源单抗新药的开发、制造、商业化及全球特异性血液制品的潜在替代,以满足广泛的临床需求,造福病患。

公司福利
一、假期福利
双休/法定节假日/加班调休假/全薪病假/灵感充电假/婚假/产检假/产假/陪产假/育儿假/独生子女护理假/司龄奖励假/五天七小时工作制
二、个人发展福利
晋升/外训/学历提升补贴/技能/职称补贴/授课补贴
三、保障福利
社保/公积金/年终奖金/年度体检/高温补贴/ 夜班补贴/洁净区补贴/误餐补贴/周日餐补/司龄津贴/通勤补贴/通讯补贴/内部推荐奖励/全勤奖/园区餐卡/履职补贴/良好办公环境/应急药箱/淋浴房/母婴室/实习生意外险/实习生租房补贴/应届生过渡期租房补贴
四、活动福利
司庆活动/羽毛球比赛/篮球比赛/公司团建/行政部组织的不定期活动/入职大礼包/返岗欢迎礼


珠海研发中心:珠海市金湾区智造大街6C栋二楼
珠海生产基地:珠海市金湾区三灶国际健康港#6楼

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

泰诺麦博 Financing History (2 rounds)

Manage
A+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 7亿人民币
  • Investor: 国中资本,招银国际,尚信资...

泰诺麦博 How Fast Is Hiring Growing? (169 open positions)

Manage
Note: How fast is hiring at 珠海泰诺麦博制药股份有限公司 growing? 泰诺麦博2025: 473 openings (up 586%), 2024: 69 openings (down 18%), 2023: 84 openings (up 47%), 2022: 57 openings (down 12%), 2021: 65 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

泰诺麦博 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 560%
  • 2024: Down 44%
  • 2023: Flat 0%-
  • 2022: Up 800%
泰诺麦博 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 珠海泰诺麦博制药股份有限公司 growing? 泰诺麦博Master's recruitment over the years: 2025: 33 openings (up 560%), 2024: 5 openings (down 44%), 2023: 9 openings (flat), 2022: 9 openings (up 800%), 2021: 1 openings.

泰诺麦博 Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
泰诺麦博 Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 珠海泰诺麦博制药股份有限公司 growing? 泰诺麦博Doctorate recruitment over the years: 2026: 3 openings (up 61%), 2025: 3 openings (up 560%).

泰诺麦博 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 珠海泰诺麦博制药股份有限公司? Based on an analysis of 泰诺麦博's job postings over the past year, "医疗卫生/美容保健类" demand: 8.8%, "生物/制药/化工/环保类": 6.6%, "科研类": 3.9%, "其他(研发和技术类)": 3.6%, "计算机/网络/技术类": 3.5%, "机械/仪器仪表类": 0.5%. For reference only.

泰诺麦博 — What Are the Salaries Like? (748 records)

Manage
salary range: 2K - 50K, 51% of roles pay ¥15-30K
Note: salary statistics are based on 748 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 珠海泰诺麦博制药股份有限公司?泰诺麦博51% of positions earn 15-30K, Fresh graduate salary: ¥6.4K。Zhuhai salary ranking top 35,销售类 average salary ¥21.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 泰诺麦博

(More)
Are salaries high at 珠海泰诺麦博制药股份有限公司? We provide: 医药代表,推广,地区经理,ba,合规,财务,bp,销售,qa,实习生,市场,法务,信息,招商,临床,会计,医院代表,助理工程,研究员,pm. Click to view detailed salary analysis by job.

泰诺麦博 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

泰诺麦博 Related Industry Tags

Job Category

  • 销售类
    62.3% of total 62.3%
  • 市场/公关/媒介类
    21.4% of total 21.4%
  • 经营管理类
    13.2% of total 13.2%
  • 客户服务类
    10.2% of total 10.2%

Education

  • 本科
    58.4% of total 58.4%
  • 大专
    29.3% of total 29.3%
  • 硕士
    9.1% of total 9.1%
  • 不限
    2.3% of total 2.3%

Experience

  • 3-5年
    32.1% of total 32.1%
  • 1-3年
    22.6% of total 22.6%
  • 5-10年
    21.5% of total 21.5%
  • 不限
    20.1% of total 20.1%
View Detailed Analysis

What does 珠海泰诺麦博制药股份有限公司 require? Who is 泰诺麦博 hiring? 泰诺麦博 recruitment: 销售类占比最多占62.3%,其次是市场/公关/媒介类占21.4%. What education can get in at 泰诺麦博? 本科占比最多占58.4%,其次是大专占29.3%. High education required at 泰诺麦博? 硕士占9.1%,博士占0.7%. Work experience required at 泰诺麦博? 3-5年占比最多占32.1%,其次是1-3年占22.6%. Where are the job locations at 泰诺麦博? 珠海占比最多占20.7%,其次是北京占13.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 39,146.4262万(元)
Legal Representative: HUAXIN LIAO
Date Established:
Credit Code: 91440400MA4UKN8G5L
Registered Address: 珠海市金湾区珠海大道6366号6#厂房一楼110室

Partners & Suppliers

泰诺麦博与科兴控股签署战略合作协议,共同开发抗新冠全人源单克隆抗体药物。 Source
合作客户 新药合作研发
泰诺麦博与中国生物共同开发抗新冠全人源单克隆抗体药物,中国生物提供临床开发和商业化资源。 Source
合作客户 新药合作研发

People who follow 泰诺麦博 also follow

泰诺麦博 Competitors (Similar Companies)

“An internationally leading modern pharmaceutical flagship enterprise”
制药/药业 医药 生物制药 神经系统疾病药物
“Dedicated to the research, development, production, and commercializat”
“专注于核酸诊断试剂核心原料领域”
义齿 义齿加工 齿科 健康体检
“让生命更有价值”
医药 制药/药业 抗生素 抗肿瘤药
医药 生物医药 多肽合成 药物研发
制药/药业 医药 生产 医药分析
“Dedicated to the research and development of molecularly targeted drug”
“A comprehensive enterprise specializing in R&D, production and sales o”
“Technological innovation and commercial application of pharmaceutical ”
“专业从事临床诊断试剂与医疗仪器”
制药/药业 医药 医药中间体 医药工业
“AI technology R&D company”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates